Dr. Santosh Kesari, MD
Claim this profileProvidence Saint John's Health Center
Studies Glioblastoma
Studies Brain Tumor
11 reported clinical trials
16 drugs studied
Area of expertise
1Glioblastoma
MET positive
MET negative
2Brain Tumor
MET positive
MET negative
Affiliated Hospitals
Clinical Trials Santosh Kesari, MD is currently running
AdAPT-001
for Cancer
AdAPT-001 is an oncolytic virus that is injected directly into the tumor or via intraarterial administration. The purpose of this study is to find out if AdAPT-001 is safe and tolerable. The next step is to find out if AdAPT-001 if efficacious with or without a checkpoint inhibitor.
Recruiting1 award Phase 217 criteria
Keto Diet vs Standard Cancer Diet
for Glioblastoma
This is a Phase 2, randomized two-armed, multi-site study of 170 patients with newly diagnosed glioblastoma multiforme. Patients will be randomized 1:1 to receive Keto Diet, or Standard Anti-Cancer Diet. All patients will receive standard of care treatment for their glioblastoma. The Keto Diet intervention will be for an 18-week period and conducted by trained research dietitians. Daily ketone and glucose levels will be recorded to monitor Keto Diet adherence. This two-armed randomized multi-site study aims to provide evidence to support the hypothesis that a Keto Diet vs. Standard Anti-Cancer Diet improves overall survival in newly diagnosed glioblastoma multiforme patients who receive standard of care treatment.
Recruiting0 awards Phase 2
More about Santosh Kesari, MD
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Santosh Kesari, MD has experience with
- OKN-007
- Temozolomide
- Bevacizumab
- Lomustine
- AdAPT-001
- Optune®
Breakdown of trials Santosh Kesari, MD has run
Glioblastoma
Brain Tumor
Recurrence
Tumors
Chondrosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Santosh Kesari, MD specialize in?
Santosh Kesari, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved MET positive patients, or patients who are MET negative.
Is Santosh Kesari, MD currently recruiting for clinical trials?
Yes, Santosh Kesari, MD is currently recruiting for 4 clinical trials in Santa Monica California. If you're interested in participating, you should apply.
Are there any treatments that Santosh Kesari, MD has studied deeply?
Yes, Santosh Kesari, MD has studied treatments such as OKN-007, Temozolomide, Bevacizumab.
What is the best way to schedule an appointment with Santosh Kesari, MD?
Apply for one of the trials that Santosh Kesari, MD is conducting.
What is the office address of Santosh Kesari, MD?
The office of Santosh Kesari, MD is located at: Providence Saint John's Health Center, Santa Monica, California 90404 United States. This is the address for their practice at the Providence Saint John's Health Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.